Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
STIVARGA Filmtabl 40 mg 3 Ds 28 Stk
Drug
Stivarga, Filmtabletten
metastasiertes Kolorektalkarzinom, gastrointestinale Stromatumoren, Leberzellkarzinom
07.16.1. – cytostatics
HAM – Human medicine
FILM – Film-coated tablet
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
2/27/2013
12/31/9999
Dosage strength
Stivarga 40 mg, Filmtabletten
metastasiertes Kolorektalkarzinom, gastrointestinale Stromatumoren, Leberzellkarzinom
01
Z – approved
Package
7680628080023
No information made available
A/R – Authorised / referenced
3 x 28 tablet(s)
002
Z – approved
Declaration
Component
40 mg regorafenibum
cellulosum microcristallinum
carmellosum natricum conexum
14.01 mg natrium
magnesii stearas
povidonum
silica colloidalis anhydrica
lecithinum ex soja
macrogolum 3350
poly(alcohol vinylicus)
talcum
E 172 (rubrum)
E 172 (flavum)
E 171
carmellosum natricum conexum
14.01 mg natrium
magnesii stearas
povidonum
silica colloidalis anhydrica
lecithinum ex soja
macrogolum 3350
poly(alcohol vinylicus)
talcum
E 172 (rubrum)
E 172 (flavum)
E 171
Spezialitätenliste***
SL
-
-
3239.80
None
Yes
10%
No
Authorisation holder
7601001002593
Bayer (Schweiz) AG
Uetlibergstrasse 132
8045 Zürich (ZH)
Uetlibergstrasse 132
8045 Zürich (ZH)
Date of revision of the text
7/4/2024
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.